Recently efforts are being made to explore the hidden wealth of medicinal plants for contraceptive use. With the exciting prospects of

gene therapy, herbal medicine remains one of the common forms of therapy, available too much of world’s population, to maintain the health and to treat diseases. In the present study was aimed to evaluate the anti-fertility effect of newly developed herbal oral contraceptive (HOCS) suspension containing 70% methanol extracts of Capparis aphylla aerial part and Carica papaya leaves. Previous studies found that the both extracts showed potent anti-fertility www.selleckchem.com/products/Neratinib(HKI-272).html activity. These findings suggested that suitable formulations of these materials could serve as potential herbal drug candidates. Hence, the authors tried to develop suitable herbal formulations of the extracts of these medicinal plants to exploit their potential anti-fertility activity. The administration and the induction of systemic effects of the drugs under research were done by oral route. The suspension dosage form is suitable for the products that are physically and chemically stable.2 and 3

Methanol (70% v/v) extracts of C. aphylla aerial part (MECA), C. papaya leaves (MECP) were used in this study. MLN8237 clinical trial Oral suspensions that contained extract of plants showing potential male anti-fertility activity were prepared by the trituration method using a suitable suspending agent and other excipients. 4 The amount of individual plant required for the formulation HOCS was calculated based on the therapeutically effective dose (dose at which plant showed maximum activity) of that plant. That is, the maximum effective dose of individual plants was found to be 300 mg/kg for MECA, and 300 mg/kg for MECP. Thus, the average effective

dose of combined extracts is calculated by dividing sum of maximum effective doses individual plant by number of plants. Therefore, the content of individual plant required for formulating HOCS were calculated from the average effective dose of the combined extracts by ratio proportion method. More over the authors developed three doses of pharmaceutically stable oral suspensions containing only 200 mg/kg, 300 mg/kg and 400 mg/kg per body weight contraceptive principles with convincing quality control parameters. Therefore, the present study was taken to assess the comparative contraceptive/anti-fertility activity of different doses of HOCS for their effective contraceptive efficacy in mature male rats. The effect of HOCS formulation on spermatogenesis of sexually mature male rats was determined by studying the following parameters: The cauda epididymal duct on one side was exposed and incised. The connective tissue capsule around the epididymis was teased out and the duct was uncoiled.